Status:
COMPLETED
Nasal Versus Oronasal Mask in Continuous Positive Airway Pressure (CPAP) Treatment of Patients Affected by Obstructive Sleep Apnea Syndrome (OSAS).
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Osa Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Continuous positive airway pressure (CPAP) is considered the gold standard treatment for patients with moderate to severe obstructive sleep apnea (OSA). Nasal and oronasal masks are often used interc...
Detailed Description
Continuous positive airway pressure (CPAP) is considered the gold standard treatment for patients with moderate to severe obstructive sleep apnea (OSA). The treatment of OSA with CPAP was first propo...
Eligibility Criteria
Inclusion
- confirmed diagnosis of OSA and use of CPAP treatment
- age\> or equal to 18 years old
- sign of informed consent
Exclusion
- none
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04681196
Start Date
January 1 2021
End Date
June 1 2021
Last Update
November 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliero Universitaria Policlinico S. Orsola-Malpighi
Bologna, Italy, 40138